Datta A, Biolatti LV, Reardon M, Bigos K, Lunj S, Eke H, Desai S, Hyder P, Reeves K, Barraclough L, Haslett K, Fjeldbo CS, Lyng H, O'Connor JPB, West CML, Hoskin P, Choudhury A (2026) Hypoxia-associated gene signature for uterine cervical cancer Radiother Oncol, 223, 111703 (in press) DOI 10.1016/j.radonc.2026.111703, PubMed 42492734 Stonyte V, Fjeldbo CS, Langiu M, Joy-Immediato M, Swaminathan P, Humagain PS, Valencia-Pesqueira LM, Lindbergsengen L, Campsteijn C, Lyng H, Grallert B (2026) Elevated GCN2 levels in cancer cells confer protection from mitotic stress and faster cell movement Cell Oncol (Dordr), 49 (4) DOI 10.1007/s13402-026-01214-5, PubMed 42113357 Landsverk HB, Sandquist LE, Bay LTE, Hauge S, van Bijsterveldt L, Lindbergsengen L, Lund-Andersen C, Kanduri C, Lyng H, Fjeldbo CS, Hompland T, Humphrey TC, SyljuÄsen RG (2026) Transcription termination counteracts DNA damage after WEE1 inhibition Nucleic Acids Res, 54 (3) DOI 10.1093/nar/gkaf1487, PubMed 41569153 More publications
Contact informationHeidi Lyng, Department of Radiation Biology, Institute for Cancer ResearchNorwegian Radium Hospital, Oslo University HospitalPhone +47 22 78 1478, e-mail: heidi.lyng@ous-hf.no